1977P Efficacy of talazoparib and avelumab as a maintenance treatment in patients with advanced/metastatic urothelial carcinoma (mUC) whose disease did not progress after a first-line platinum-based chemotherapy (PBCT): The GETUG-TALASUR trial

Autor: Coquan, E., Boughalem, E., Pouessel, D., Lequesne, J., Calcagno, F., Grellard, J-M., Christy, F., Mahammedi, H., Ladoire, S., Borchiellini, D., Leman, R., Bazille, C., Fontugne, J., Crouzet, L., Flechon, A., Serrate, C., Gravis, G., Clarisse, B., Thiery Vuillemin, A., Joly Lobbedez, F.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S1144-S1145
Databáze: ScienceDirect